munity attitudes, and experimental aspects of organ recovery, training and education. Our goal is to assure that the option of organ donation is available to all potential donor families, successfully recover transplantable organs, and recover costs.
This protocol is subject to the oversight of an advisory committee, as recommended by the consensus conference participants. This committee is composed of community members who have an interest in seeing that the program is sensitive to community needs and concerns. The Community Oversight Committee is comprised of nurses, physicians, morticians, clergy, legal services representatives, D.C. government officials, educators, and local transplant groups. The advisory committee is currently chaired by the Director of the Office of Decedent Affairs (ODA) and reports directly to the Office of Community Affairs of the Medlantic Healthcare Group. This advisory committee meets at least on a quarterly basis and began in December 1993. All policies, protocols, and practices were available for review by the Committee Oversight Committee.
Regular reports are submitted to the Institutional Review Board (IRB) for continuing review. Although the Rapid Organ Recovery Program (RORP) does not constitute a research program, we are requesting the same consideration under the existing internal review mechanisms. We feel that because of the nature of the program and the community that we serve, the IRB must be kept apprised of the program’s progression and offer advice or direction as the board deems appropriate.
Potential deceased organ donors will include all patients pronounced cardiac dead in MedSTAR, an ICU or the emergency department at Washington Hospital Center (WHC). The potential donors will have the following acceptability criteria:
Patients should generally not be over 60 years of age or younger than 18 years of age (<18 with next-of-kin consent). Exceptions will be made on a case by case basis.
Patients must have a known time of death.
Patients must not have active, untreated systemic bacterial sepsis at the time of death.
Patients must not have documented positive testing for HIV, HBsAg, or HTLV1.